The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Obesity expert Dr. Naomi Parrella of Rush University joins Marie Saavedra to talk about the new study and the impact for ...

The skyrocketing popularity of weight-loss drugs like Wegovy, one of a class of drugs called GLP-1s, is fast becoming a state ...

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

A major study involving two million people has unveiled surprising effects of weight-loss drugs like Ozempic and Wegovy.

"I thought that thin people just had more willpower,” the 70-year-old said Oprah Winfrey is opening up about the revelation she had about “thin people.” On the Jan. 14 episode of The Oprah Podcast, ...